Effect of ependymal and pial surfaces on convection-enhanced delivery.

OBJECT Convection-enhanced delivery (CED) is increasingly used to investigate new treatments for central nervous system disorders. Although the properties of CED are well established in normal gray and white matter central nervous system structures, the effects on drug distribution imposed by ependymal and pial surfaces are not precisely defined. To determine the effect of these anatomical boundaries on CED, the authors infused low MW and high MW tracers for MR imaging near ependymal (periventricular) and pial (pericisternal) surfaces. METHODS Five primates underwent CED of Gd-diethylenetriamine pentaacetic acid (Gd-DTPA; MW 590 D) or Gd-bound albumin (Gd-albumin; MW 72,000 D) during serial real-time MR imaging (FLAIR and T1-weighted sequences). Periventricular (caudate) infusions were performed unilaterally in 1 animal (volume of infusion [Vi] 57 microl) and bilaterally in 1 animal with Gd-DTPA (Vi = 40 mul on each side), and bilaterally in 1 animal with Gd-albumin (Vi = 80 microl on each side). Pericisternal infusions were performed in 2 animals with Gd-DTPA (Vi = 190 microl) or with Gd-albumin (Vi = 185 microl) (1 animal each). Clinical effects, MR imaging, and histology were analyzed. RESULTS Large regions of the brain and brainstem were perfused with both tracers. Intraparenchymal distribution was successfully tracked in real time by using T1-weighted MR imaging. During infusion, the volume of distribution (Vd) increased linearly (R2 = 0.98) with periventricular (mean Vd/Vi ratio +/- standard deviation; 4.5 +/- 0.5) and pericisternal (5.2 +/- 0.3) Vi, but did so only until the leading edge of distribution reached the ependymal or pial surfaces, respectively. After the infusate reached either surface, the Vd/Vi decreased significantly (ependyma 2.9 +/- 0.8, pia mater 3.6 +/- 1.0; p < 0.05) and infusate entry into the ventricular or cisternal cerebrospinal fluid (CSF) was identified on FLAIR but not on T1-weighted MR images. CONCLUSIONS Ependymal and pial boundaries are permeable to small and large molecules delivered interstitially by convection. Once infusate reaches these surfaces, a portion enters the adjacent ventricular or cisternal CSF and the tissue Vd/Vi ratio decreases. Although T1-weighted MR imaging is best for tracking intraparenchymal infusate distribution, FLAIR MR imaging is the most sensitive and accurate for detecting entry of Gd-labeled imaging compounds into CSF during CED.

[1]  M. Brechbiel,et al.  Backbone-substituted DTPA ligands for 90Y radioimmunotherapy. , 1991, Bioconjugate chemistry.

[2]  M. Brechbiel,et al.  Real-time, Image-Guided, Convection-Enhanced Delivery of Interleukin 13 Bound to Pseudomonas Exotoxin , 2006, Clinical Cancer Research.

[3]  P F Morrison,et al.  Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time. , 1999, Journal of neurosurgery.

[4]  Volker Sturm,et al.  Imaging‐guided convection‐enhanced delivery and gene therapy of glioblastoma , 2003, Annals of neurology.

[5]  John A Butman,et al.  Image-guided convection-enhanced delivery of gemcitabine to the brainstem. , 2007, Journal of neurosurgery.

[6]  A. Vortmeyer,et al.  Real-time in vivo imaging of the convective distribution of a low-molecular-weight tracer. , 2005, Journal of neurosurgery.

[7]  M. Bock,et al.  Contrast optimization of fluid‐attenuated inversion‐recovery (FLAIR) MR imaging in patients with high CSF blood or protein content , 2000, Magnetic resonance in medicine.

[8]  R. Mulhern,et al.  Quality of survival among children treated for brain stem glioma. , 1994, Pediatric neurosurgery.

[9]  E. Oldfield,et al.  Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single-photon emission computerized tomography imaging. , 1997, Journal of neurosurgery.

[10]  P F Morrison,et al.  Focal delivery during direct infusion to brain: role of flow rate, catheter diameter, and tissue mechanics. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[11]  Michele R Aizenberg,et al.  Convection perfusion of glucocerebrosidase for neuronopathic Gaucher's disease , 2005, Annals of neurology.

[12]  E. Oldfield,et al.  Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors , 1997, Nature Medicine.

[13]  P F Morrison,et al.  Convection-enhanced delivery of macromolecules in the brain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Mirzadeh,et al.  Radiometal labeling of immunoproteins: covalent linkage of 2-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid ligands to immunoglobulin. , 1990, Bioconjugate chemistry.

[15]  Cynthia Sung,et al.  Convective distribution of macromolecules in the primate brain demonstrated using computerized tomography and magnetic resonance imaging. , 2003, Journal of neurosurgery.

[16]  John A Butman,et al.  Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion. , 2002, Journal of neurosurgery.

[17]  Christoph Pedain,et al.  INTRACEREBRAL INFUSATE DISTRIBUTION BY CONVECTION‐ENHANCED DELIVERY IN HUMANS WITH MALIGNANT GLIOMAS: DESCRIPTIVE EFFECTS OF TARGET ANATOMY AND CATHETER POSITIONING , 2007, Neurosurgery.

[18]  G J Murray,et al.  Image-guided, direct convective delivery of glucocerebrosidase for neuronopathic Gaucher disease , 2007, Neurology.

[19]  P. J. Hoopes,et al.  Visualization of intravenously administered contrast material in the CSF on fluid-attenuated inversion-recovery MR images: an in vitro and animal-model investigation. , 2000, AJNR. American journal of neuroradiology.